Provided is a novel quinoline derivative inhibiting the bromodomain and extra terminal domain (BET) proteins, and a pharmaceutical composition comprising the same which can be useful for prevention or treatment of a precancerous transformation or a cancer.
提供了一种新颖的
喹啉衍
生物,能够抑制
溴结构域和额外末端结构域(BET)蛋白,以及包含该衍
生物的药物组合物,可用于预防或治疗癌前病变或癌症。